Immunization in the context of adolescent health

Similar documents
The State of Measles and Rubella in the WHO European Region

Addressing Complacency, Convenience and Confidence

Measles and rubella monitoring January 2015

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Vaccine Acceptance, Hesitancy and Refusal

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Alcohol-related harm in Europe and the WHO policy response

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Monthly measles and rubella monitoring report

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Recommendations for vaccination

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Highlighting in the WHO European Region:

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Çeşme Izmir, Turkey, September 2013

Tailoring Seasonal Influenza Immunization Programmes for Health Care Workers

Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%

European monthly measles monitoring (EMMO)

European status report on alcohol and health Leadership, awareness and commitment

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

EUVAC.NET A surveillance network for vaccine-preventable diseases

The perceived full public health value of vaccines and vaccine hesitancy among patients and providers. Pauline Paterson

SEVENTH MEETING OF THE EUROPEAN REGIONAL VERIFICATION COMMISSION FOR MEASLES AND RUBELLA ELIMINATION (RVC) June 2018 Paris, France

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

Understanding vaccine hesitancy in a post-factual era

A view from the ground what have we learned? Joanne Yarwood National Programme Manager Public Health England 1 st February 2017

Update on Progress and Challenges in Achieving Measles and Rubella Targets

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

Development of Palliative Care services in different countries

5/16/18. Increasing Rates of Influenza Immunization in the Office Setting. Introduction. Is There a Problem?

Critical immunity thresholds for measles elimination

European Status report on Alcohol and Health

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

The challenge of vaccine hesitancy in the European Union

SURVEILLANCE REPORT. Measles and rubella surveillance

A report on the epidemiology of selected vaccine-preventable diseases in the European Region

The challenge of obesity in the WHO European Region

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

How to present the European Vaccine Action Plan (EVAP)

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

WCPT COUNTRY PROFILE December 2017 HUNGARY

Tenth meeting of the European Technical Advisory Group of Experts on Immunization: Outcomes and recommendations

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Third meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) November 2014 Copenhagen, Denmark

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Immunization highlights. European Vaccine Action Plan progress report for 2016

Decreasing vaccine preventable diseases in adults

Eliminating measles and rubella and preventing congenital rubella infection

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Welcome to the new EURO Immunization Monitor

Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC)

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses

Updates from the European Centre for Disease Prevention and Control

Measles and Rubella Global Update SAGE April 2018

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Vaccine confidence in Europe: time for action

HPAI H5(N8) in Member States in poultry, captive and wild birds

MSD FOR MOTHERS PROGRAMME REPORT MAKING PREGNANCY AND CHILDBIRTH SAFER IN EUROPE

Consultation on Strengthened EU cooperation against vaccine preventable diseases

Global Measles and Rubella Update November 2018

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

OVERVIEW 2018 VACCINE UPDATE 3/19/ VACCINE SCHEDULE

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

The cancer burden in the European Union and the European Region: the current situation and a way forward

Achieving the United Nations 2030 Sustainable Development Goals, Health 2020 and the SEE 2020 goals: how to make it happen?

Seventh GF-TADs for Europe Steering Committee meeting (RSC7)

Summary. Primary care data. Week 49/2014. Season

Report of the 26th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

Vaccine preventable diseases and vaccination programs Adherence of the Public and stakeholders: ups and downs

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

Second European Immunization Week meeting. Copenhagen September 2007

LEBANON. WCPT COUNTRY PROFILE December 2018

Impact of 5As Strategy on Vaccination Coverage against influenza in Mexico. Season

WHO position paper on rubella vaccines

Progress in maternal and child health: Uzbekistan and WHO European Region

Overall survival: 1 st line therapy

HPV, Cancer and the Vaccination Programme

NHSE London Immunisation 2 year Plan

Transcription:

Immunization in the context of adolescent health Sao Paulo, Brazil, 24-25 July 2018 Advocacy, promotion and communication across the spectrum of adolescence Vaccine hesitancy and acceptance Katrine Bach Habersaat, Technical Officer Vaccine-preventable Diseases and Immunization programme WHO Regional Office for Europe

WHO Region of Europe 53 Member States 15 time zones (capital cities -2 to +5 hr from Copenhagen) Population 900 Million Infants 11 Million < 5yr 55 Million <15yr 157 Million 2

Trends of Immunization Coverage of Major Antigens in European Region, 1980-2016* *Data source: WHO/UNICEF Estimates (WUENIC) 3

Outbreaks occurring in several susceptible populations

Measles Verification Status, 2012 2017 19 23 21 24 33 3 14 13 12 14 2 9 18 14 4 4 3 2 2 9 4 2 7 9 37 4 1 10 Eliminated Interrupted - 24m Interrupted - 12m Endemic Inconclusive No Report 2012 2013 2014 2015 2016 2017 Pending RVC Clarifications: one country

Number of measles in the WHO European Region, 2007-2018* 2016: 5273 cases in 34 countries 2017: 22 360 cases in 43 countries 2018*: 18 329 cases in 36 countries Bulgaria 24 410 France 19 997 Ukraine 14 079 Georgia 11 060 Kyrgyzstan 18 097 Romania 6201 Italy 5910 Ukraine 13529 * Preliminary data for Jan-Mar 2018 Data source: CISID, extracted 8 May 2018 6

Age distribution and vaccination status of measles, WHO European Region, 2017 (n=22,351) Number of reported measles cases 9 000 8 000 7 000 6 000 5 000 4 000 3 000 2 000 1 000 Unknown status Vaccinated 2 doses Vaccinated 1 dose Unvaccinated 0 <1 1-4 5-9 10-14 15-19 20 Age group (years) Data source: CISID, extracted 16 April 2018 7

8

Vaccine hesitancy Complex Context-specific Varies across time, place and vaccines SAGE Working Group on Vaccine hesitancy Report 2014

Tailoring Immunization Programmes (TIP) A structured process informed by behavioural science and theory undertaken to understand enablers and barriers with a view to defining evidence-informed interventions to increase vaccination coverage

TIP projects Fed. Bosnia and Herzegovina TIP initiated 2017 Target: health workers and parents (childhood vacc.) Armenia TIP initiated 2017 Target: medical experts (childhood vacc.) Montenegro TIP initiated 2014 Target: health workers (influenza) Bulgaria TIP initiated 2012 Target: vulnerable and Roma populations (childhood vacc.) United Kingdom TIP initiated 2014 Target: orthodox Jewish Charedi community (measles) Sweden TIP initiated 2013 Targets: Somali community + Undocumented migrants + Anthroposophic community (childhood vacc.) Lithuania TIP initiated 2014 Target: pregnant women (influenza) Country self-initiated projects inspired by the TIP approach Germany (measles) Finland (childhood immunization) Ireland (influenza) Italy (measles) Serbia TIP initiated 2017 Target: health workers (action research project) Romania Initiated 2017 (TIP-inspired) Target: parents and health workers (measles) Out of Region Australia TIP initiated 2016 Target: vulnerable communities in Maitland, NSW (childhood vaccination) Mauritania TIP initiated 2018 Target: parents and health workers (to be defined)

Case ex : United Kingdom Charedi community 12 Photo credits: Jewish News Online and Jewish Home La

Why are Sarah s children not Not enough time to discuss her concerns with doctor Does not believe measles is a serious disease immunized? Is not aware of the schedule Wanted to do it, but never got round to it Does not trust her non- Charedi doctor Believes vaccination may cause autism Info materials culturally inappropriate Opening hours not convenient Waiting time too long The waiting rooms not child friendly Community resistance against vaccination Does not trust national health authorities Religious concerns

Why are Sarah s children not Not enough time to discuss her concerns with doctor Does not believe measles is a serious disease immunized? Is not aware of the schedule Wanted to do it, but never got round to it Does not trust her non- Charedi doctor Believes vaccination may cause autism Info materials culturally inappropriate Opening hours not convenient Waiting time too long The waiting rooms not child friendly Community resistance against vaccination Does not trust national health authorities Religious concerns

Why are Sarah s children not Not enough time to discuss her concerns with doctor Does not believe measles is a serious disease immunized? Is not aware of the schedule Wanted to do it, but never got round to it Does not trust her non- Charedi doctor Believes vaccination may cause autism Info materials culturally inappropriate Opening hours not convenient Waiting time too long The waiting rooms not child friendly Community resistance against vaccination Does not trust national health authorities Religious concerns

What did we learn? Assumptions challenged Asssumptions confirmed Behavioural determinants are complex and context-specific Evidenceinformed interventions to increase coverage

What else? Better data Decision-maker attention, commitment and investment Strengthened intersectoral collaboration Critical for sustainable increase in coverage Strengthened community relations 17

In conclusion... Vaccination continues to be a great success Hesitancy is complex and highly context-specific Knowledge does not predict behaviour Beneficiaries are not always the problem - consider system weaknesses Behavioural insights allow cost-effective interventions

THANK YOU Email: Habersaatk@who.int For further information: https://www.euro.who.int/vaccine Twitter: @WHO_Europe_VPI Facebook: https://www.facebook.com/whoeurope 19

Extra 20

Limited data Limited evidence Limited capacity Limited political prioritization 21

The complexity Service delivery convenience, appeal, appropriateness Health worker education, knowledge, attitudes or ability False contraindications Poverty, health systems access Low health literacy Social and cultural norms and beliefs, social copying Inefficient monitoring of under-vaccinated Inefficient call and reminder systems Trust issues: programme response to vaccine safety events Trust issues: lack of due care in creating resilience, maintain trust Anti-vaxxers Hesitant parents of the past

Insights Assumption of a cultural/religious anti-vaccination sentiment was disproved: Reasons for vaccination refusals/delays broadly similar to the wider population Critical issue was immunization services: Lack of child-friendly waiting space; inconvenient opening hours, booking process and transportation Inadequate call/recall systems Poor monitoring of delayed/refused vaccination Inadequate funding for clinical practices, due to high number of children in the community with no additional funding Poor information access making easily available information on vaccination schedule more important 23

Interventions Increased tariffs for vaccination to cover additional cost Charedi nurse re-hired, offering vaccination through outreach and home visits Improved flexibility: booking, drop-in and vaccination in community venues Monitoring of vaccination delays/refusals improved Call/recall systems improved, more proactive reminding Information materials updated and reprinted. Leading rabbi actively advocating for immunization 24